0.39482.66% ( -0.0108 )
Closed: Oct 23, 16:00:01 (EDT)About

Bone Biologics
BBLG.US
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine.
Profile
- Company Name
- Bone Biologics Corporation
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.bonebiologics.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
